Patent ID: 8153608

Claim:
A method for therapeutically treating a patient having a disease or disorder, such method comprising administering to the patient an immunomer having the structure selected from 5′-CTGTC 1 GTTCTC-X-CTCTTGC 1 TGTC-5′ (5′-SEQ ID NO: 177-3′-X-3′-SEQ ID NO: 177-5′); 5′-TC 1 GTC 1 GTTCTG-X-GTCTTGC 1 TGC 1 T-5′ (5′-SEQ ID NO: 181-3′-X-3′-SEQ ID NO: 181-5′); 5′-TCTGTC 1 GTTCT-X-TCTTGC 1 TGTCT-5′ (5′-SEQ ID NO: 170-3′-X-3′-SEQ ID NO: 170-5′); 5′-TCG 1 TCG 1 TTCTG-X-GTCTTG 1 CTG 1 CT-5′ (5′-SEQ ID NO: 172-3′-X-3′-SEQ ID NO: 172-5′); and 5′-CTGTCG 2 TTCTC-X-CTCTTG 2 CTGTC-5′ (5′-SEQ ID NO: 171-3′-X-3′-SEQ ID NO: 171-5′); wherein X is a glycerol linker, C 1 is 1-(2′-deoxy-β-D-ribofuranosyl)-2-oxo-7-deaza-8-methylpurine, G 1 is 2′-deoxy-7-deazaguanosine and G 2 is arabinoguanosine.